University of Navarra, Pamplona, Spain
Hospital Clinic, Barcelona, Spain
Autonomous University of Barcelona, Barcelona, Spain
Harvard T.H. Chan School of Public Health, Boston, MA
University of Barcelona, Barcelona, Spain
Xabier García de Albéniz, MD, ScM, PhD, is Director of Epidemiology at RTI Health Solutions. He has a background in oncology, epidemiology, and biostatistics. Dr. Garcia de Albéniz obtained his MD at the University of Navarra (Spain). He trained as a clinical oncologist in Barcelona, while he pursued a Master's degree in biostatistics. He obtained a PhD in Medicine from the University of Barcelona and a Master of Science with a concentration in Epidemiology from the Harvard School of Public Health. Dr. García de Albéniz has worked for several years within the Program on Causal Inference, Department of Epidemiology at the Harvard T.H. Chan School of Public Health, where he maintains an affiliation as a visiting scientist and as collaborator of the CAUSALab. He currently collaborates on several academic research projects in the field of cancer comparative effectiveness and development of methods for cancer research and COVID-19 prophylaxis. Dr. García de Albéniz provides oncology and methodologic expertise to RTI-HS's Epidemiology group.